Stiripentol 500 MG Oral Capsule [Diacomit] — RxCUI 2054983
RxNorm drug concept · Semantic branded drug
RxCUI 2054983
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2054983
Official nameStiripentol 500 MG Oral Capsule [Diacomit]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDiacomit 500 MG Oral Capsule
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)3,030 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Stiripentol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Diacomit is only approved when used together with clobazam — there's no clinical evidence that it works on its own for Dravet syndrome. Part of the reason the combination works wel...
- Why does my child need to take this medication with clobazam? Can they take it alone?
- Unfortunately, drowsiness is very common with Diacomit — it happened in about two-thirds of patients in clinical trials. Part of this is because Diacomit raises clobazam levels, an...
- My child seems very sleepy since starting Diacomit. Is that normal, and what should I do?
🕸️ Concept Web — How Stiripentol 500 MG Oral Capsule [Diacomit] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Stiripentol 500 MG Oral Capsule [Diacomit]
RxCUI 2054983 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Stiripentol
2054968IN
-
Stiripentol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Diacomit
2054974BN
-
Diacomit
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Stiripentol Oral Capsule
2054972SCDF -
Stiripentol Oral Product
2054970SCDG -
Stiripentol Pill
2054971SCDG -
Stiripentol Oral Capsule [Diacomit]
2054976SBDF -
Diacomit Oral Product
2054977SBDG -
Diacomit Pill
2054978SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Stiripentol Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Stiripentol 500 MG Oral Capsule
2054981SCD -
Stiripentol 500 MG
2054980SCDC -
Stiripentol 500 MG [Diacomit]
2054982SBDC
-
Stiripentol 500 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Stiripentol 500 MG Oral Capsule
SCD · 2054981 -
Stiripentol 500 MG
SCDC · 2054980 -
Stiripentol Oral Capsule
SCDF · 2054972 -
Stiripentol Oral Product
SCDG · 2054970 -
Stiripentol Pill
SCDG · 2054971
Brand-Name Concepts
-
Stiripentol 500 MG [Diacomit]
SBDC · 2054982 -
Stiripentol Oral Capsule [Diacomit]
SBDF · 2054976 -
Diacomit Oral Product
SBDG · 2054977 -
Diacomit Pill
SBDG · 2054978 -
Diacomit
BN · 2054974
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 2054983 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68418-7939-06 | 1 BOTTLE in 1 CARTON (68418-7939-6) / 60 CAPSULE in 1 BOTTL... | Diacomit | BIOCODEX, INC. | 2018-08-21 |
| 68418-7940-06 | 1 BOTTLE in 1 CARTON (68418-7940-6) / 60 CAPSULE in 1 BOTTL... | Diacomit | BIOCODEX, INC. | 2018-08-21 |
| 68418-7941-06 | 60 PACKET in 1 CARTON (68418-7941-6) / 1 POWDER, FOR SUSPEN... | Diacomit | BIOCODEX, INC. | 2018-08-21 |
| 68418-7942-06 | 60 PACKET in 1 CARTON (68418-7942-6) / 1 POWDER, FOR SUSPEN... | Diacomit | BIOCODEX, INC. | 2018-08-21 |
Observed labelers:
BIOCODEX, INC. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.